Research Article
Management of Patients with Graves’ Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
Figure 3
Subfoveal choroidal thickness measured by EDI SDOCT in a patient with Graves’ orbitopathy (a, b) and in a healthy control (c, d). The graph (e) shows the significant increase of choroidal thickness (mean ± SD) in patients with Graves’ orbitopathy () versus controls () ().
(a) |
(b) |
(c) |
(d) |
(e) |